Dr. Opeolu Ojo, a Nigerian-born, United Kingdom-based medical researcher at the University of Wolverhampton, England, has contributed to the discovery of using frogs to treat Type 2 diabetes.
Ojo investigated the effects of combining the molecule produced by the amphibian with an existing type 2 diabetes medication component.
According to Express and Star News, Ojo led a team of medical researchers at the University of Wolverhampton who discovered that a protein generated by the East Asian bullfrog (Hoplobatrachus rugulosus) increased insulin production and improved glucose tolerance in mice.
Ojo, a professor of biochemistry, presented the latest medical research findings at the Diabetes United Kingdom Professional conference on Thursday.
People with Type 2 diabetes do not produce enough insulin, which can result in dangerously elevated blood sugar levels, indicating that those with the condition frequently require medication.
Ojo stated, "Our research has revealed the enormous potential of peptides derived from amphibian skin secretions, notably their potential clinical application as novel agents for the treatment of Type 2 diabetes.
"By combining these peptides with some of the molecules that our body naturally produces, we hope to create a safe and potent alternative to current anti-diabetic medications, which have many drawbacks, including their side effects and inability to restore the body's ability to regulate blood glucose."
Dr. Elizabeth Robertson, director of research at Diabetes UK, added, "This innovative research has identified the untapped potential of a molecule secreted by frogs, which could enhance existing type 2 diabetes drugs, leading to new and enhanced type 2 diabetes treatment options.
"We look forward to conducting additional research to determine how this innovative new combination therapy could be used to help people with type 2 diabetes manage their blood sugar levels and potentially reduce their risk of developing serious complications associated with diabetes."